ECHO Biotech Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $14M

  • Investors
  • 9

ECHO Biotech General Information

Description

Developer of scientific research services and drugs intended for exosomes technology and treatment. The company focuses on the research and clinical transformation exosome technology and combines more than ten years of basic exosome research with molecular biology, cell biology and bioinformatics technology, and has established a leading exosome research and transformation platform, providing exosomes-based scientific and technological services and innovative drugs based on exosomes as carriers, which mainly cover the fields of tumor immunity, neurology and rare diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 108, Building 1, China Resources Life Science Park
  • Baoshen South Street, Daxing District
  • Beijing
  • China
+86 010
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Room 108, Building 1, China Resources Life Science Park
  • Baoshen South Street, Daxing District
  • Beijing
  • China
+86 010

ECHO Biotech Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ECHO Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B) 06-Nov-2025 $14M Completed Generating Revenue
7. Secondary Transaction - Private 09-Jul-2024 Completed Generating Revenue
6. Later Stage VC 06-Dec-2023 Completed Generating Revenue
5. Later Stage VC (Series A2) 03-Mar-2023 Completed Generating Revenue
4. Early Stage VC (Series A1) 11-Jan-2022 Completed Generating Revenue
3. Early Stage VC (Series A) 22-Jul-2021 Completed Generating Revenue
2. Early Stage VC 29-Oct-2018 Completed Generating Revenue
1. Seed Round 05-Nov-2017 Completed Startup
To view ECHO Biotech’s complete valuation and funding history, request access »

ECHO Biotech Patents

ECHO Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250304681-A1 Anti-rage antibody, extracellular vesicle, and preparation method and use thereof Pending 29-Mar-2024
US-20250144145-A1 Engineered psd protein, extracellular vesicle, and preparation method and use thereof Pending 03-Nov-2023

ECHO Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ECHO Biotech Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Chengdu Bio-Town Investment Government Minority
Beihang Investment Growth/Expansion Minority
Qingdao Haier Venture Capital Corporate Venture Capital Minority
Zhongbo Capital Growth/Expansion Minority
Baidu Ventures Corporate Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

ECHO Biotech FAQs

  • When was ECHO Biotech founded?

    ECHO Biotech was founded in 2017.

  • Where is ECHO Biotech headquartered?

    ECHO Biotech is headquartered in Beijing, China.

  • What is the size of ECHO Biotech?

    ECHO Biotech has 29 total employees.

  • What industry is ECHO Biotech in?

    ECHO Biotech’s primary industry is Biotechnology.

  • Is ECHO Biotech a private or public company?

    ECHO Biotech is a Private company.

  • What is ECHO Biotech’s current revenue?

    The current revenue for ECHO Biotech is .

  • How much funding has ECHO Biotech raised over time?

    ECHO Biotech has raised $29.5M.

  • Who are ECHO Biotech’s investors?

    Chengdu Bio-Town Investment, Beihang Investment, Qingdao Haier Venture Capital, Zhongbo Capital, and Baidu Ventures are 5 of 9 investors who have invested in ECHO Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process